Home
ColoHealth
- Patient Information
- CLIA Laboratory
Products
About Us
- Our Team
- News

Case Study 2

CRO

Skills

Posted on

December 8, 2022

← Case Study 1 Case Study 3: ColoPlex →

Submit a Comment Cancel reply

You must be logged in to post a comment.

Search

Topics

Articles
Company Details
News and Events
Products & Pipeline
Research & Development

Recent Posts

Existing FDA-approved blood test for colorectal cancer screening, ColoHealth™, formerly known as Epi proColon.
Development of an algorithm combining blood-based biomarkers, fecal immunochemical test, and age for population-based colorectal cancer screening
OPEN OPPORTUNITIES
Colorectal Cancer Awareness Month: New test for prevention and early detection
Living East TN-New Day Diagnostics with New Screening Tool for National Colorectal Cancer Awareness Month

New Day Diagnostics Home

ColoHealth Home

Call Us: 865-299-6250
Email Us: [email protected]

Legal

BSI Medical Device Quality Assurance Mark

CLIA#: 44D2184836

Knoxville Chamber of Commerce Member

Copyright © 2012-2024. All Rights Reserved.
Web Site usage is subject to New Day Diagnostics / EDP Biotech’s Web Site Usage and Privacy Policy. Copyright ©2024 New Day Diagnostics, All Rights Reserved. All other copyrights are owned by their respective owners.